Drug – bio-affecting and body treating compositions – Inorganic active ingredient containing – Heavy metal or compound thereof
Reexamination Certificate
2006-10-17
2006-10-17
Pak, John (Department: 1616)
Drug, bio-affecting and body treating compositions
Inorganic active ingredient containing
Heavy metal or compound thereof
C514S492000, C514S909000
Reexamination Certificate
active
07122209
ABSTRACT:
Oral compositions containing an effective amount of a tungsten compound (VI), preferably a tungstate salt, more preferably sodium tungstate (Na2WO4), are useful in controlling obesity/overweightness in non-diabetic mammals, including humans. The anti-obesity effect of sodium tungstate dihydrate in rats has been determined in a cafeteria-diet-induced obesity model. Said obese rats are good models of obese, non-diabetic mammals, including humans. The prophylactic, therapeutic and/or cosmetic treatment resulting from this invention is surprising. It provides advantages such as effectiveness, lack of toxicity and relatively low price in comparison with other treatments in prior art. Hence, the oral compositions according to the invention are useful for the treatment of obesity/overweightness in non-diabetic mammals, including humans.
REFERENCES:
patent: 5595763 (1997-01-01), Guinovart et al.
patent: 2 108 642 (1997-12-01), None
patent: 60 02 5 928 (1985-02-01), None
Cecil Textbook of Medicine, W.B. Saunders Co., Philadelphia, 1992, vol. 2, p. 1166.
J. Matsumoto, “Vanadate, Molybdate and Tungstate for Orthomolecular Medicine”. Medical Hypotheses, 1994, vol. 43, p. 177-182, p. 179, table 1.
J.D. Foster et al, “Tungstate: a Potent Inhibotor of multifunctional Glucose-6-Phasphatase”. Archiv. Biochem. Biophys., 1998, vol. 354, No. 1, p. 125-132.
International Search Report, 2002.
Claret Carles Marc
Fernandez Alvarez Josefa
Gomis De Barbara Ramon
Guinovart Cirera Joan-Josep
Ostrolenk Faber Gerb & Soffen, LLP
Pak John
Quimica Farmaceutica Bayer S.A.
LandOfFree
Oral compositions for the treatment of non-diabetic obese... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oral compositions for the treatment of non-diabetic obese..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oral compositions for the treatment of non-diabetic obese... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3658829